Genomma Lab Internacional SAB de CV
BMV:LABB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genomma Lab Internacional SAB de CV
BMV:LABB
|
MX |
|
J
|
Jasmine International PCL
SET:JAS
|
TH |
|
SPS Commerce Inc
F:S86
|
US |
|
Travere Therapeutics Inc
NASDAQ:TVTX
|
US |
|
N
|
NVIDIA Corp
DUS:NVD
|
US |
|
N
|
Nomura Holdings Inc
XMUN:NSE
|
JP |
|
N
|
NETGEAR Inc
SWB:NGJ
|
US |
|
Waqoo Inc
TSE:4937
|
JP |
|
S
|
Shanghai Huayi Group Corp Ltd
SSE:600623
|
CN |
|
Societe Generale SA
PAR:GLE
|
FR |
|
S
|
Swiss Re AG
OTC:SSREF
|
CH |
|
Ems Chemie Holding AG
OTC:EMSHF
|
CH |
|
T
|
Thales SA
XMUN:CSF
|
FR |
|
Keyence Corp
OTC:KYCCF
|
JP |
|
Noritake Co Ltd
F:NO4
|
JP |
|
Isuzu Motors Ltd
F:ISUA
|
JP |
|
Enovix Corp
F:6Q81
|
US |
|
Eagle Materials Inc
NYSE:EXP
|
US |
|
A
|
Arkema SA
DUS:V1S
|
FR |
|
L
|
Lokotech Group AS
OSE:LOKO
|
NO |
|
B
|
Biogen Inc
F:IDP
|
US |
|
M
|
Macy's Inc
F:FDO
|
US |
|
T
|
Ternium SA
BMV:TX
|
LU |
|
Ajinomoto Co Inc
TSE:2802
|
JP |
Bankruptcy Probability
Genomma Lab Internacional SAB de CV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genomma Lab Internacional SAB de CV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MX |
|
Genomma Lab Internacional SAB de CV
BMV:LABB
|
12.5B MXN |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
651.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
365.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
364.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
226.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
192.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
306.2B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genomma Lab Internacional SAB de CV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genomma Lab Internacional SAB de CV has total debt of 2.4B MXN. This includes both short-term (0 MXN) and long-term (2.4B MXN) debt.
You can find a full breakdown on its Balance Sheet.